TransMedics Group, Inc.TMDXNASDAQ
Loading
Year-over-year research & development expense growth
3Y CAGR
+5.0%/yr
Annual compound
Percentile
P78
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 23.38% |
| 2024 | -11.54% |
| 2023 | 135.97% |
| 2022 | 20.21% |
| 2021 | 18.44% |
| 2020 | -5.23% |
| 2019 | 45.50% |
| 2018 | -8.70% |
| 2017 | -4.35% |
| 2016 | 0.00% |